Search

everythinglearnresearchcommunity

for

Search:↓

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

ITK inhibitors may effectively treat alopecia areata.

Dutasteride showed some prevention of prostate issues but also had limitations, especially with high-grade tumors.

MK-386 lowers DHT in blood and skin but not in semen.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

MK-5108 is safe and shows potential against tumors, especially alone.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

The inhibitor affects androgen metabolism but not ovarian function.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

A new method accurately detects illegal JAK inhibitors in hair loss cosmetics.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.